Company
FutureTech II Acquisition Corp. (0001889450)
Standardized SEC financial data for FutureTech II Acquisition Corp. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001889450 · Biological Products, (No Diagnostic Substances).
Return on equity
8.4%
Free cash flow
-$1.9M
Current ratio
0.07×
Income statement
| USD | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| SG&A expense | $366K | $743K | $1.5M |
| Interest expense | $100K | $100K | $100K |
| Pretax income | $1.0M | $3.9M | -$472K |
Standardized from FutureTech II Acquisition Corp.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Cash & equivalents | $5K | $263K | — | — |
| Total current assets | $5K | $420K | $1.4M | $1.7M |
Cash flow
| USD | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Operating cash flow | -$601K | -$1.8M | -$1.9M |
| Investing cash flow | -$117.3M | $61.8M | $36.9M |
| Financing cash flow | $118.2M | -$60.3M |
Get 0001889450 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001889450/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001889450/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"